Robert Eil

5.0k total citations · 2 hit papers
30 papers, 2.1k citations indexed

About

Robert Eil is a scholar working on Oncology, Immunology and Hepatology. According to data from OpenAlex, Robert Eil has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Immunology and 7 papers in Hepatology. Recurrent topics in Robert Eil's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (7 papers). Robert Eil is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (7 papers). Robert Eil collaborates with scholars based in United States, United Kingdom and Malaysia. Robert Eil's co-authors include Nicholas P. Restifo, Rahul Roychoudhuri, Christopher A. Klebanoff, Madhusudhanan Sukumar, Douglas C. Palmer, Zhiya Yu, Tori N. Yamamoto, Suman K. Vodnala, David Clever and Shashank J. Patel and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Robert Eil

29 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ionic immune suppression within the tumour microenvironment limits T cell effector function

2016 489 citations Robert Eil, Suman K. Vodnala et al. Nature profile →
T cell stemness and dysfunction in tumors are triggered by a common mechanism

2019 409 citations Suman K. Vodnala, Robert Eil et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Eil United States	14	1.1k	1.0k	739	257	222	30	2.1k
Jason Miska United States	27	897 0.8×	1.4k 1.3×	1.1k 1.4×	339 1.3×	486 2.2×	73	2.8k
Claudia Paret Germany	20	938 0.9×	818 0.8×	942 1.3×	116 0.5×	213 1.0×	43	1.9k
Anna E. Vilgelm United States	23	1.0k 1.0×	630 0.6×	773 1.0×	132 0.5×	196 0.9×	48	1.9k
Kristin DePeaux United States	8	881 0.8×	1.1k 1.1×	755 1.0×	286 1.1×	677 3.0×	11	2.1k
Deepak Kanojia United States	22	788 0.7×	579 0.6×	773 1.0×	238 0.9×	292 1.3×	48	1.9k
Venkatesh Krishnan United States	20	758 0.7×	961 0.9×	1.1k 1.5×	205 0.8×	285 1.3×	35	2.3k
Ryan D. Whetstone United States	5	754 0.7×	978 1.0×	692 0.9×	174 0.7×	625 2.8×	8	1.8k
Natalie Rittenhouse United States	11	612 0.6×	1.1k 1.0×	651 0.9×	181 0.7×	492 2.2×	13	1.9k
Paolo Vignali United States	8	710 0.7×	1.1k 1.0×	697 0.9×	220 0.9×	595 2.7×	17	2.0k
Shashank J. Patel United States	10	608 0.6×	664 0.6×	644 0.9×	149 0.6×	169 0.8×	20	1.4k

Countries citing papers authored by Robert Eil

Since Specialization

Citations

This map shows the geographic impact of Robert Eil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eil more than expected).

Fields of papers citing papers by Robert Eil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Eil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eil. The network helps show where Robert Eil may publish in the future.

Co-authorship network of co-authors of Robert Eil

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Eil. A scholar is included among the top collaborators of Robert Eil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Eil. Robert Eil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pelz, Katherine R., et al.. (2024). Hepatic signal transducer and activator of transcription‐3 signalling drives early‐stage pancreatic cancer cachexia via suppressed ketogenesis. Journal of Cachexia Sarcopenia and Muscle. 15(3). 975–988. 6 indexed citations

Kardosh, Adel, Robert Eil, Emerson Y. Chen, et al.. (2024). A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion. Annals of Surgical Oncology. 31(10). 6537–6545. 3 indexed citations

Jenkins, Chelsea, et al.. (2023). Intracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function. Cancer Immunology Research. 12(1). 36–47. 8 indexed citations

Eil, Robert, Khashayar Farsad, Kathryn J. Fowler, et al.. (2023). Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations. Cellular and Molecular Gastroenterology and Hepatology. 16(6). 881–894. 18 indexed citations

Lopez, Charles D., Adel Kardosh, Skye C. Mayo, et al.. (2023). Updates to NeoOPTIMIZE: An open-label, phase II trial and biomarker discovery platform to assess the efficacy of adaptive switching of modified FOLFIRINOX (mFFX) or gemcitabine/nab-paclitaxel (GA) as a neoadjuvant strategy for patients with resectable/borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 41(4_suppl). TPS776–TPS776. 2 indexed citations

Sutton, Thomas L., Brett S. Walker, Elizabeth N. Dewey, et al.. (2022). Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis. Surgery. 173(6). 1314–1321. 12 indexed citations

Sutton, Thomas L., Brett S. Walker, Charles D. Lopez, et al.. (2021). Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?. The American Journal of Surgery. 221(6). 1114–1118. 11 indexed citations

Walker, Brett S., Thomas L. Sutton, Robert Eil, et al.. (2021). Conventional hepatic arterial anatomy? Novel findings and insights of a multi-disciplinary hepatic arterial infusion pump program. The American Journal of Surgery. 221(6). 1188–1194. 3 indexed citations

Grant, Francis M., Jie Yang, James Clarke, et al.. (2020). BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression. The Journal of Experimental Medicine. 217(9). 46 indexed citations

10.

Gurusamy, Devikala, Amanda N. Henning, Tori N. Yamamoto, et al.. (2020). Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies. Cancer Cell. 37(6). 818–833.e9. 116 indexed citations

11.

Yamamoto, Tori N., Ping‐Hsien Lee, Suman K. Vodnala, et al.. (2019). T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. Journal of Clinical Investigation. 129(4). 1551–1565. 110 indexed citations

12.

Klebanoff, Christopher A., Joseph G. Crompton, Anthony Leonardi, et al.. (2017). Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight. 2(23). 160 indexed citations

13.

Eil, Robert, Suman K. Vodnala, David Clever, et al.. (2016). Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 537(7621). 539–543. 489 indexed citations breakdown →

14.

Clever, David, Rahul Roychoudhuri, Michael G. Constantinides, et al.. (2016). Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. Cell. 166(5). 1117–1131.e14. 199 indexed citations

15.

Cruz, Anthony, Madhu Ramaswamy, Christopher A. Klebanoff, et al.. (2016). Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction. Nature Communications. 7(1). 13895–13895. 47 indexed citations

16.

Palmer, Douglas C., Geoffrey Guittard, Zulmarie Franco, et al.. (2015). Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance. The Journal of Experimental Medicine. 212(12). 2095–2113. 139 indexed citations

17.

Assadipour, Yasmine, Saïd C. Azoury, Young Ki Hong, et al.. (2015). Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors. The American Journal of Surgery. 212(1). 40–46. 5 indexed citations

18.

Roychoudhuri, Rahul, Robert Eil, & Nicholas P. Restifo. (2015). The interplay of effector and regulatory T cells in cancer. Current Opinion in Immunology. 33. 101–111. 114 indexed citations

19.

Crompton, Joseph G., Benjamin A. Nacev, Saïd C. Azoury, et al.. (2014). Traumatic ventricular septal defect resulting in severe pulmonary hypertension. Journal of Surgical Case Reports. 2014(10). rju107–rju107. 1 indexed citations

20.

Eil, Robert, et al.. (2012). Intracranial Hemangiopericytoma Focally Recurrent to the Pelvis. Journal of Cancer Therapy. 3(5). 487–490. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact